Pricing

Skye Bioscience Inc (SKYE)

followers ·
Sector: HEALTH CARE
Industry: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS
CEO: Punit S. Dhillon
Employees: 11
Web site: skyebioscience.com
11250 EL CAMINO REAL, SUITE 100, SAN DIEGO, CA, 92130
(858) 410-0266
    Formally known as:
  • EMERALD BIOSCIENCE ORD SHS
  • Nemus Bioscience
  • NEMUS BIOSCIENCE INC COM STK
  • NEMUS BIOSCIENCE, INC. COMMON
Stock Split History
DateRatio
2023-09-08 1:250
All 13F Filers Prior Change Hedge Funds 1 Prior Change
Skye Bioscience, Inc. discovers, develops, and commercializes cannabinoid-based molecules. The company's lead product candidate is SBI-100, which is in Phase I trials for the treatment of glaucoma and ocular hypertension.
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available